Company profile
ELITE PHARMACEUTICALS INC /NV/ CIK 1053369
Ticker
ELTP (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Northvale, NJ 07647
Fiscal year end
2026 (FY)
Key Financials
Revenue
$148.87M
Net income
$44.87M
Total assets
$138.29M
Total liabilities
$39.41M
Stockholders' equity
$98.88M
Cash & equivalents
$30.27M
Operating income
$49.11M
Operating cash flow
$23.75M
Capital expenditures
$925.6K
Fiscal year 2026, via 10-K filed 2026-06-29. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
33.0%
Net margin
30.1%
Free cash flow
$22.82M
Free cash flow margin
15.3%
Liabilities / assets
28.5%
Equity / assets
71.5%
CapEx / revenue
0.6%
Operating cash flow / net income
0.53×
Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026
$148.87M
$44.87M
$138.29M
$39.41M
$98.88M
2025
$84.04M
-$4.31M
$96.39M
$42.87M
$53.52M
2024
$56.63M
$20.11M
$83.65M
$26.07M
$57.58M
2023
$34.16M
$3.56M
$40.90M
$11.94M
$28.96M
2022
$32.26M
$8.90M
$35.15M
$9.93M
$25.22M
Company Details
SIC code
2834
State of incorporation
NJ
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-10
Financials filed via
Form 10-K
filed 2026-06-29
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Northvale, NJ 07647
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.